Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
The Oncologist
|
February 23, 2024
A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX
Jacob K Jamison, Michael S May, Alexander G Raufi, et al.
The Oncologist
|
April 25, 2021
Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature
Michael May, Alexander G Raufi, Sina Sadeghi, et al.
International Journal of Molecular Sciences
|
January 11, 2025
Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue
Michael S May, Heekuk Park, Dalia H Moallem, et al.
Cancer Reports (Hoboken, N.J.)
|
February 5, 2022
Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients
Myles A Ingram, Brianna N Lauren, Yoanna Pumpalova, et al.
The Journal of Biological Chemistry
|
May 23, 2002
PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing
Lin Wang, Gulam A Manji, Jill M Grenier, et al.
Seminars in Oncology
|
December 18, 2020
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Winston Wong, Claire Brieva, Michael May, et al.
Journal of Surgical Oncology
|
September 30, 2024
Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy
Alexander S Thomas, Parisa Tehranifar, Wooil Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Gulam A Manji, Brian A Van Tine, Shing M Lee, et al.
Journal of Surgical Oncology
|
September 1, 2022
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer
Alexander S Thomas, Wooil Kwon, David P Horowitz, et al.
Genome Medicine
|
February 10, 2023
Pervasiveness of HLA allele-specific expression loss across tumor types
Ioan Filip, Anqi Wang, Oleksandr Kravets, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
The Oncologist
|
February 23, 2024
A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX
Jacob K Jamison, Michael S May, Alexander G Raufi, et al.
The Oncologist
|
April 25, 2021
Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature
Michael May, Alexander G Raufi, Sina Sadeghi, et al.
International Journal of Molecular Sciences
|
January 11, 2025
Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue
Michael S May, Heekuk Park, Dalia H Moallem, et al.
Cancer Reports (Hoboken, N.J.)
|
February 5, 2022
Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients
Myles A Ingram, Brianna N Lauren, Yoanna Pumpalova, et al.
The Journal of Biological Chemistry
|
May 23, 2002
PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing
Lin Wang, Gulam A Manji, Jill M Grenier, et al.
Seminars in Oncology
|
December 18, 2020
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Winston Wong, Claire Brieva, Michael May, et al.
Journal of Surgical Oncology
|
September 30, 2024
Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy
Alexander S Thomas, Parisa Tehranifar, Wooil Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Gulam A Manji, Brian A Van Tine, Shing M Lee, et al.
Journal of Surgical Oncology
|
September 1, 2022
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer
Alexander S Thomas, Wooil Kwon, David P Horowitz, et al.
Genome Medicine
|
February 10, 2023
Pervasiveness of HLA allele-specific expression loss across tumor types
Ioan Filip, Anqi Wang, Oleksandr Kravets, et al.
Page
of 5